Siltuximab Demonstrates Efficacy Against Multicentric Castleman’s Disease

Positive trial results for siltuximab in the treatment of multicentric Castleman’s disease...

ESMO members: your membership includes full access to OncologyPRO Daily News, created exclusively for you by medwireNews. Sign in now to access this page.